🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stage II Breast Cancer

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer NCT06178159Phase 21 site📍 Shanghai RemeGen Co., Ltd. · Tests: Disitamab Vedotin Injection, Pertuzumab Injection, Toripalimab BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer NCT06085742Phase 21 site📍 Chicago University of Illinois at Chicago · Tests: Cyclophosphamide, Methotrexate, Capecitabine A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer NCT07597629Phase 21 site📍 Harbin CSPC Megalith Biopharmaceutical Co.,Ltd. · Tests: SYS6023, KN026 Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer NCT05981001Phase 1, Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Surgery for harvesting tumor-draining lymph nodes, Cyclophosphamide, Fludarabine, Tumor-draining lymph node-derived lym… Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer NCT06954831Phase 27 sites📍 Arcadia📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration, Radiatio… Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer NCT03412877Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Cyclophosphamide, Fludarabine, Aldesleukin, Individual Patient TCR-Transduced PBL, Pembrolizumab (KEYTRUDA(R)) Palbociclib and Pembrolizumab In Central Nervous System Metastases NCT02896335Phase 22 sites📍 Boston📍 Boston Massachusetts General Hospital · Tests: Palbociclib, Pembrolizumab Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer NCT07076485Phase 25 sites📍 Loveland📍 Jacksonville📍 Voorhees Township M.D. Anderson Cancer Center · Tests: Ultrahypofractionated Radiation, Moderately Hypofractionated Radiation Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors NCT06819215Phase 1, Phase 21 site📍 Jinan Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Tests: VB15010 18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer NCT05982496Phase 21 site📍 Milan Università Vita-Salute San Raffaele · Tests: FES, PET/MRI A, Translational analysis Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection NCT05334069n/a747 sites📍 Anchorage📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Questionnaire Administration, Biospecimen Collection Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab NCT06516289Phase 21 site📍 Shanghai Fudan University · Tests: HRS-1167, Famitinib, Camrelizumab HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) NCT07441889Phase 1, Phase 21 site📍 Charlottesville University of Virginia · Tests: HER2 FPBMC Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors NCT06950086Phase 1, Phase 22 sites📍 Shanghai📍 Shanghai TYK Medicines, Inc · Tests: TYK-00540 Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy NCT06885671NA1 site📍 Prince George British Columbia Cancer Agency · Tests: Multiple Fraction PBI, Single Fraction PBI TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients NCT05535192NA4 sites📍 Boston📍 Cleveland📍 Pittsburgh Dana-Farber Cancer Institute · Tests: THRIVE, Health Education Support Program Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC NCT05228951Phase 21 site📍 Shenyang Shengjing Hospital · Tests: Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole Asciminib in HER2+ Breast Cancer Brain Metastases NCT07136428Phase 1, Phase 21 site📍 Durham Duke University · Tests: Asciminib and Trastuzumab Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Breast Cancer NCT06185972Phase 21 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Definity, Sonalleve Focused Ultrasound Device Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT) NCT06928701NA1 site📍 Novara University of Eastern Piedmont · Tests: omega-3 (n-3 Lc-PUFA), EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) plus a source of palmitoleic acid (he… A Phase II Clinical Study of Treatment With Disitamb Vedotin Plus Pyrotinib in HER2-positive Early Breast Cancer NCT06001086Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Disitamb Vedotin ,pyrotinib Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC) NCT07011654Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Sacituzumab govitecan, Naxitamab SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) NCT06401005Phase 21 site📍 Wuhan Hubei Cancer Hospital · Tests: Cadonilimab (AK104) Efficacy and Safety Study of Disitamab Vedotin + RC148 vs. Albumin-Paclitaxone ± Toripalimab in HR-/HER2-low Breast Cancer NCT06642545Phase 21 site📍 Beijing RemeGen Co., Ltd. · Tests: Disitamab Vedotin, RC148, Albumin-bound Paclitaxone, Toripalimab SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer NCT06340230Phase 21 site📍 Shenyang Shengjing Hospital · Tests: SHR-A1811 Injection + Adebrelimab Injection, SHR-A1811 Injection + Adebrelimab Injection, SHR-A1811 Injection Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer NCT06942234Phase 1, Phase 21 site📍 Shanghai Jiangsu Alphamab Biopharmaceuticals Co., Ltd · Tests: JSKN016, Capecitabine, Paclitaxel (albumin bound), Eribulin, Pembrolizumab Pre-Operative Window of ET to Inform RT Decisions (POWER II) NCT06507618Phase 36 sites📍 New Haven📍 Charlottesville📍 Culpeper University of Virginia · Tests: Tamoxifen, Letrozole, Anastrozole, or Exemestane PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) NCT07222215Phase 21 site📍 Boston Kristina A. Fanucci · Tests: Capecitabine, Elacestrant Effectiveness of an N-acetylcysteine and Urea-based Cream in Prevention of Capecitabine-induced HAND-foot Syndrome in Breast Cancer Patients NCT06639178NA2 sites📍 Aviano📍 Udine Centro di Riferimento Oncologico - Aviano · Tests: DECLARAN cream A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer NCT06827236Phase 1, Phase 281 sites📍 Beverly Hills📍 Newport Beach📍 Port Saint Lucie BioNTech SE · Tests: BNT323, BNT327
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy